My original comment referred to the 95% effectiveness in PFE top line numbers from when we got the clinical trial readout rather than the 91% in the article. I

My original comment referred to the 95% effectiveness in PFE top line numbers from when we got the clinical trial readout rather than the 91% in the article. I was responding to the parent comment. Further, the JNJ clinical trial data was from a population where the Brazilian variant, the most serious of the variants, was likely more widespread than this PFE data which seems to focus more on the relatively less dangerous South African variant.